HHealthcare Read More What’s next for Novo Nordisk’s obesity drug CagriSemaFebruary 24, 2026 A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…
HHealthcare Read More Eli Lilly launches Zepbound obesity drug pen with one month of dosesFebruary 23, 2026 An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March…
BBusiness Read More Novo Nordisk stock falls as weight loss drug fails to beat Eli LillyFebruary 23, 2026 Novo Nordisk stock fell 15% Monday after it said its next-generation weight loss drug didn’t meet its key…
BBusiness Read More 5 things to know before the stock market opens MondayFebruary 9, 2026 This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Monday. Congratulations to the…
MMedication Read More Hims & Hers falls 8% after Novo’s legal threat. Here’s the latestFebruary 6, 2026 Rafael Henrique | SOPA Images | AP The stock of Hims & Hers dropped in premarket trading early…
MMedication Read More Hims & Hers announces Wegovy pill copy; Novo Nordisk vows legal actionFebruary 6, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…
EEntertainment Read More Thursday's big stock stories: What’s likely to move the market in the next trading session – CNBCFebruary 5, 2026 Thursday’s big stock stories: What’s likely to move the market in the next trading session CNBCCommodities Cold War: Trump’s…
BBusiness Read More 5 things to know before the stock market opens WednesdayFebruary 4, 2026 This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Wednesday. In addition to…
HHealthcare Read More Pfizer’s monthly obesity injection drove shows promise in trialFebruary 3, 2026 Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it…
HHealthcare Read More Eli Lilly CEO David Ricks talks Medicare coverage of obesity pillsJanuary 31, 2026 Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major…
HHealthcare Read More Eli Lilly plans $3.5 billion Pennsylvania plant for obesity drugsJanuary 30, 2026 Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik…
HHealthcare Read More 15 drugs added to Medicare price negotiationsJanuary 28, 2026 Boxes of the drug trulicity, made by Eli Lilly and Company, sit on a counter at a pharmacy…